Literature DB >> 8307257

The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.

J J Robert1, B Rakotoambinina, I Cochet, V Foussier, J Magre, D Darmaun, D Chevenne, J Capeau.   

Abstract

Insulin resistance is present in patients suffering from lipoatrophic syndromes long before the onset of diabetes mellitus. Thus, the decreased peripheral glucose disposal may not be the only mechanism of hyperglycaemia. The kinetic parameters of glucose homeostasis were evaluated in six young females aged 15, 16, 18, 19 and 24 years with generalized lipoatrophy; one patient was studied both at 12 and 15 years. Insulin resistance was evaluated in vivo by the hyperinsulinaemic euglycaemic clamp (3-4 insulin infusion rates from 1 to 100 mU/kg.min). All patients showed a rightward shift of the dose-response curve, indicating decreased insulin sensitivity. In two patients, maximal glucose disposal was moderately decreased, while in five patients it was dramatically reduced (3.6-6.9 mg/kg.min). Fasting plasma glucose was variable (4.3-18.3 mmol/l) and did not correlate with peripheral glucose disposal rates. Hepatic glucose production, measured by infusion of [6,6-2H] glucose, varied from 1.7 to 8.3 mg/kg.min and was significantly correlated with fasting plasma glucose. The overproduction of glucose despite basal hyperinsulinism suggested hepatic insulin resistance, which was confirmed by the abnormal response to constant unlabelled glucose infusion (2 mg/kg.min) in five patients. In conclusion, impaired glucose tolerance seems to develop in generalized lipoatrophy with aggravated peripheral insulin resistance. The present data show that fasting hyperglycaemia is mainly the consequence of increased hepatic glucose production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307257     DOI: 10.1007/BF00400807

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Lipodystrophy and hepatomegaly, with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin.

Authors:  R D LAWRENCE
Journal:  Lancet       Date:  1946-05-18       Impact factor: 79.321

Review 2.  The role of protein kinase C in insulin action.

Authors:  R V Farese; M L Standaert; T Arnold; B Yu; T Ishizuka; J Hoffman; M Vila; D R Cooper
Journal:  Cell Signal       Date:  1992-03       Impact factor: 4.315

3.  Congenital lipodystrophy: An endocrine study in three siblings. I. Disorders of carbohydrate metabolism.

Authors:  C Huseman; A Johanson; M Varma; R M Blizzard
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

4.  Studies in congenital generalized lipodystrophy (Seip-Berardinelli syndrome). I. Development of diabetes.

Authors:  S Oseid
Journal:  Acta Endocrinol (Copenh)       Date:  1973-03

5.  Glucose turnover and disposal in maturity-onset diabetes.

Authors:  H F Bowen; J A Moorhouse
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

6.  Fat cell function and insulin in a patient with generalized lipodystrophy.

Authors:  B Senior; L Loridan
Journal:  J Pediatr       Date:  1969-06       Impact factor: 4.406

7.  Insulin resistance in a boy with congenital generalized lipodystrophy.

Authors:  H Tsukahara; K Kikuchi; H Kuzuya; E Ito; Y Oda; A Kosaki; T Kakehi; H Nishimura; K Yamada; Y Yoshimasa
Journal:  Pediatr Res       Date:  1988-12       Impact factor: 3.756

8.  The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes.

Authors:  B S Keenan; R T Kirland; A J Garber; A H Rubenstein; J H Holcombe; V E Potts; G W Clayton
Journal:  Metabolism       Date:  1980-12       Impact factor: 8.694

9.  Insulin resistance and acanthosis nigricans: evidence for a postbinding defect in vivo.

Authors:  P Cohen; C Harel; R Bergman; D Daoud; Z Pam; N Barzilai; M Armoni; E Karnieli
Journal:  Metabolism       Date:  1990-10       Impact factor: 8.694

10.  Metabolic studies in lipoatrophic diabetes: mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism.

Authors:  M Beylot; G Sautot; M Laville; R Cohen
Journal:  Diabete Metab       Date:  1988 Jan-Feb
View more
  1 in total

1.  Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.

Authors:  Jean-Marc Guettier; Jean Y Park; Elaine K Cochran; Christine Poitou; Arnaud Basdevant; Muriel Meier; Karine Clément; Jocelyne Magré; Phillip Gorden
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-10       Impact factor: 3.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.